1 - 3 of 3
1
Conference item icon
Conference item

A phase 3, randomized trial of magrolimab in combination with venetoclax and azacitidine in previously untreated patients with acute myeloid leukemia ineligible for intensive chemotherapy (ENHANCE-3)

  • Daver, N, Liu, K, Werneke, S, et al.
  • 2022-10-13
2
Conference item icon
Conference item

A lineage of myeloid cells independent of Myb and hematopoietic stem cells

  • Perdiguero, E, Schulz, C, Chorro, L, et al.
  • 2012-09-01
3
Conference item icon
Conference item

Generation of an inducible cartilage-specific deleter using human aggrecan enhancer/promoter that is trackable in vivo using luciferase

  • Lo Cascio, L, Lim, N, Layyous, A, et al.
  • 2012-11-01
FILTER RESULTS

TO TOP